The opportunity within the regulatory T-cell therapies market is projected to grow at an annualized rate of ~45%, till 2035, claims Roots Analysis London, March 09, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Regulatory T-Cell (Tregs) Therapies Market, 2021 – 2035” report to its list of offerings. Given the various...

The TCR-based therapies market is projected to be worth around USD 4.4 billion, by 2030, claims Roots Analysis London, July 15, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “TCR-based Therapies Market, 2021-2030” report to its list of offerings. Modified TCR-based adoptive T-cell...

The CAR-T therapies market is characterized by a healthy pipeline of promising therapies, and is projected to be worth around USD 14 Billion in 2030, claims Roots Analysis London, April 06, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “CAR-T Therapies Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic...